Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
---|---|---|---|---|---|
CHEK-ATP154 | Human | HEK293/Human STEAP1 Stable Cell Line | |||
ST1-H5283 | Human | Human STEAP1 Full Length Protein, Twin-Strep,His Tag (Detergent) |
|
||
SCCHO-ATP121 | Human | CHO/Human STEAP1 Stable Cell Line Development Service |
Fig. FACS analysis of STEAP1 on HEK293/Human STEAP1 Stable Cell Line.
FACS assay shows that Anti-STEAP1 antibody can bind to HEK293/Human STEAP1 Stable Cell Line. HEK293/Human STEAP1 Stable Cell Line was red line, Negative control HEK293 cells was grey line(QC tested).
Expression analysis of human STEAP1 on CHO/Human STEAP1 Stable Cell Line by FACS.
Cell surface staining was performed on CHO/Human STEAP1 Stable Cell Line or negative control cell using anti-human STEAP1 antibody followed by staining with PE anti-human IgG Fc Antibody.
Anti-STEAP1 Antibody captured on Protein A Chip can bind Human STEAP1 Full Length Protein, Twin-Strep,His Tag (Cat. No. ST1-H5283) with an affinity constant of 2.95 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
89Zr-DFO-MSTP2109A | Phase 2 Clinical | Memorial Sloan Kettering Cancer Center, Genentech Inc | Prostatic Neoplasms | Details | |
STEAP1 CART Cell Therapy(PromiCell) | Phase 2 Clinical | PromiCell Therapeutics Inc, Fred Hutchinson Cancer Research Center | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details | |
Xaluritamig | AMG-509 | Phase 1 Clinical | Xencor Inc, Amgen Inc | Prostatic Neoplasms, Castration-Resistant | Details |
ABBV-969 | ABBV-969; ABBV969 | Phase 1 Clinical | Abbvie Inc, Immunogen Inc | Prostatic Neoplasms, Castration-Resistant | Details |
89Zr-DFO-MSTP2109A | Phase 2 Clinical | Memorial Sloan Kettering Cancer Center, Genentech Inc | Prostatic Neoplasms | Details | |
STEAP1 CART Cell Therapy(PromiCell) | Phase 2 Clinical | PromiCell Therapeutics Inc, Fred Hutchinson Cancer Research Center | Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details | |
Xaluritamig | AMG-509 | Phase 1 Clinical | Xencor Inc, Amgen Inc | Prostatic Neoplasms, Castration-Resistant | Details |
ABBV-969 | ABBV-969; ABBV969 | Phase 1 Clinical | Abbvie Inc, Immunogen Inc | Prostatic Neoplasms, Castration-Resistant | Details |
This web search service is supported by Google Inc.